SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

iBio, Inc. (IBIO) (CIK 0001420720) (IBIO)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Jun. 18, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Mar. 4, 2026 CORRESP Neutral/Informational Moderate iBio, Inc. has submitted a request to the SEC to accelerate the effective date of its Registration Statement on Form S-3, originally filed on February 27, 2026. The company seeks … Read Filing EDGAR
Mar. 4, 2026 UPLOAD Neutral/Informational Low The SEC correspondence dated March 4, 2026, informs Martin Brenner, CEO of iBio, Inc., that the SEC has not reviewed and will not review the company's registration statement filed… Read Filing EDGAR
Jun. 18, 2025 CORRESP Neutral/Informational Moderate iBio, Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-3, originally filed on June 13, 2025. The company … Read Filing EDGAR
Jun. 18, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to iBio, Inc. that it will not review the company's registration statement filed on June 13, 2025. The letter emphasizes that the responsibility for the a… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.